IL71150A - Growth hormone releasing factor analogs,their preparation and pharmaceutical compositions containing them - Google Patents
Growth hormone releasing factor analogs,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL71150A IL71150A IL71150A IL7115084A IL71150A IL 71150 A IL71150 A IL 71150A IL 71150 A IL71150 A IL 71150A IL 7115084 A IL7115084 A IL 7115084A IL 71150 A IL71150 A IL 71150A
- Authority
- IL
- Israel
- Prior art keywords
- growth hormone
- hormone releasing
- releasing factor
- grf
- preparation
- Prior art date
Links
- 101710142969 Somatoliberin Proteins 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 2
- 102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 title 1
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 101000825742 Homo sapiens Somatoliberin Proteins 0.000 abstract 2
- 102100022831 Somatoliberin Human genes 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000007788 liquid Substances 0.000 abstract 1
- 239000007791 liquid phase Substances 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 239000011347 resin Substances 0.000 abstract 1
- 229920005989 resin Polymers 0.000 abstract 1
- 238000010532 solid phase synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
1. Claims for the Contracting States : BE CH DE FR GB IT LI LU NL SE Polypeptides of the general formula (Leu**27 )-GRF wherein GRF represents at least the first 28 amino acids of the full sequence of natural human growth hormone releasing factor and wherein the carboxyl terminus of the molecule is present in free form or as the amide. 1. Claims for the Contracting State : AT A method for the preparation of polypeptides of the general formula (Leu**27 )-GRF wherein GRF represents at least the first 28 amino acids of the full sequence of natural human growth hormone releasing factor and wherein the carboxyl terminus of the molecule is present in free form or as the amide, characterized in that (a) the protecting groups of a protected polypeptide of corresponding amino acid sequence, which has been synthetized according to the liquid phase method, are cleaved off in a manner known per se, or (b) a carrier resin-bound protected polypeptide of corresponding amino acid sequence, which has been synthetized according to the solid phase method, is treated with anhydrous liquid HF.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47270083A | 1983-03-07 | 1983-03-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL71150A0 IL71150A0 (en) | 1984-06-29 |
IL71150A true IL71150A (en) | 1987-02-27 |
Family
ID=23876594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL71150A IL71150A (en) | 1983-03-07 | 1984-03-05 | Growth hormone releasing factor analogs,their preparation and pharmaceutical compositions containing them |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0121764B1 (en) |
JP (1) | JPH0786120B2 (en) |
AT (1) | ATE53220T1 (en) |
AU (1) | AU574064B2 (en) |
CA (1) | CA1254000A (en) |
DE (1) | DE3482387D1 (en) |
DK (1) | DK162130C (en) |
IE (1) | IE57097B1 (en) |
IL (1) | IL71150A (en) |
NZ (1) | NZ207378A (en) |
ZA (1) | ZA841638B (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4518586A (en) * | 1983-01-13 | 1985-05-21 | The Salk Institute For Biological Studies | GRF Analogs III |
IL70530A (en) * | 1983-01-13 | 1986-09-30 | Salk Inst For Biological Studi | Synthetic peptides having growth hormone releasing factor activity and compositions containing them |
BG49718A3 (en) * | 1983-07-15 | 1992-01-15 | Bio Technology General Corp | Method for preparing of polypeptid with superoxiddismutasne activitty |
DE3327007A1 (en) * | 1983-07-27 | 1985-02-07 | Hoechst Ag, 6230 Frankfurt | PRODUCTION OF POLYPEPTIDES WITH AN ACID-CARBOXYTERMINUS |
AU575843B2 (en) * | 1983-08-10 | 1988-08-11 | The Administrators Of The Tulane Eductional Fund | Growth hormone releasing peptides |
US4617149A (en) * | 1983-09-21 | 1986-10-14 | Eli Lilly And Company | Growth hormone release factor analogs |
CA1340265C (en) * | 1985-01-18 | 1998-12-15 | Kirston E. Koths | Oxidation resistant muteins |
US4734399A (en) * | 1985-08-06 | 1988-03-29 | Hoffmann-La Roche Inc. | Growth hormone releasing factor analogs |
JPS62187490A (en) * | 1985-08-12 | 1987-08-15 | シンテツクス(ユ−・エス・エイ)インコ−ポレイテツド | Bovine growth hormone release factor derivative |
EP0448513A3 (en) * | 1990-03-21 | 1991-12-27 | Japat Ltd | Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof |
IL98638A (en) * | 1990-06-29 | 1995-07-31 | Hoffmann La Roche | Human growth hormone releasing factor analogs, their preparation and pharmaceutical compositions containing them |
DE69108192T2 (en) * | 1990-12-10 | 1995-07-20 | Hoffmann La Roche | Process for the enzymatic production of GRF (1-44) NH2. |
WO1992018531A1 (en) * | 1991-04-09 | 1992-10-29 | F. Hoffmann-La Roche Ag | Growth hormone releasing factor analogs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL70530A (en) * | 1983-01-13 | 1986-09-30 | Salk Inst For Biological Studi | Synthetic peptides having growth hormone releasing factor activity and compositions containing them |
US4617149A (en) * | 1983-09-21 | 1986-10-14 | Eli Lilly And Company | Growth hormone release factor analogs |
-
1984
- 1984-03-05 ZA ZA841638A patent/ZA841638B/en unknown
- 1984-03-05 AU AU25268/84A patent/AU574064B2/en not_active Ceased
- 1984-03-05 AT AT84102383T patent/ATE53220T1/en not_active IP Right Cessation
- 1984-03-05 IL IL71150A patent/IL71150A/en not_active IP Right Cessation
- 1984-03-05 EP EP84102383A patent/EP0121764B1/en not_active Expired - Lifetime
- 1984-03-05 DK DK151884A patent/DK162130C/en not_active IP Right Cessation
- 1984-03-05 CA CA000448864A patent/CA1254000A/en not_active Expired
- 1984-03-05 NZ NZ207378A patent/NZ207378A/en unknown
- 1984-03-05 DE DE8484102383T patent/DE3482387D1/en not_active Expired - Fee Related
- 1984-03-06 IE IE537/84A patent/IE57097B1/en not_active IP Right Cessation
- 1984-03-06 JP JP59041481A patent/JPH0786120B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE53220T1 (en) | 1990-06-15 |
DK151884A (en) | 1984-09-08 |
DK151884D0 (en) | 1984-03-05 |
JPS59176238A (en) | 1984-10-05 |
ZA841638B (en) | 1984-10-31 |
DK162130B (en) | 1991-09-23 |
AU2526884A (en) | 1984-09-13 |
DK162130C (en) | 1992-03-02 |
CA1254000A (en) | 1989-05-09 |
EP0121764A2 (en) | 1984-10-17 |
NZ207378A (en) | 1989-05-29 |
EP0121764B1 (en) | 1990-05-30 |
IE57097B1 (en) | 1992-04-22 |
IL71150A0 (en) | 1984-06-29 |
IE840537L (en) | 1984-09-07 |
AU574064B2 (en) | 1988-06-30 |
DE3482387D1 (en) | 1990-07-05 |
JPH0786120B2 (en) | 1995-09-20 |
EP0121764A3 (en) | 1985-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL71150A (en) | Growth hormone releasing factor analogs,their preparation and pharmaceutical compositions containing them | |
IL72512A (en) | Crystal suspensions of insulin derivatives,processes for their preparation and pharmaceutical compositions containing them | |
EP0456152A3 (en) | Peptidamides, their process of preparation and the agents containing these peptides as fibrin-thrombin clotting inhibitors | |
EP0218712A4 (en) | Novel procoagulant proteins. | |
IL130524A (en) | Stable liquid interferon formulations, a kit containing the same and a process for stabilizing the same | |
GR3019560T3 (en) | New insulin derivatives, process for their preparation, their use and pharmaceutical compositions containing them | |
IL85020A0 (en) | Pancreatic secretory trypsin inhibitor and variants thereof,process expression vector and recombinant host therefor and pharmaceutical compositions containing it | |
DE69525544D1 (en) | PEPTIDE ANALOGS OF HUMAN, BASIC MYELINE PROTEIN WITH SUBSTITUTION IN POSITION 91 FOR TREATING MULTIPLE Sclerosis | |
ES478717A1 (en) | Lipopeptides, process for their preparation and pharmaceutical compositions containing them. | |
ES2095255T3 (en) | ANALOGS OF SUBSTITUTION OF PEPTIDES MAGAININA. | |
EP0330700A4 (en) | Human prourokinase-like polypeptide. | |
IL65937A (en) | Peptides related to corticotropin releasing factor and analogs thereof and pharmaceutical compositions containing them | |
GB1002041A (en) | New polypeptides and process for their manufacture | |
ATE91286T1 (en) | VESSEL ACTIVE PEPTIDES. | |
CA1267086C (en) | Method of administering diuretic atrial peptides | |
GB1539102A (en) | Pharmaceutical compositions including low molecular weight polypeptides | |
DE59008515D1 (en) | New CNS active hexapeptides with anti-amnestic effects. | |
CS206393B1 (en) | Method of making the neurohypophysar hormones and analogues thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RH | Patent void |